51³Ô¹ÏÍø¹ÙÍø

Bi/ond and 51³Ô¹ÏÍø¹ÙÍø collaboration offers a significant advancement for DMD research and drug discovery.

51³Ô¹ÏÍø¹ÙÍø will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and 51³Ô¹ÏÍø¹ÙÍø Founde...

51³Ô¹ÏÍø¹ÙÍø featured as one of Europe's fastest-growing startups in Sifted.

51³Ô¹ÏÍø¹ÙÍø selected to join the ‘Future Fifty’ 2024 cohort as one of the UK’s most exciting technology companies.

51³Ô¹ÏÍø¹ÙÍø's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to indiv...

51³Ô¹ÏÍø¹ÙÍø announce first project in multi-year collaboration agreement with The Michael J. Fox Foundation to generate products for r...

51³Ô¹ÏÍø¹ÙÍø's CEO, our cell programming approach and our products prominently covered in synthetic biology article.

Ginkgo Technology Network brings together over 25 partners across an array of capabilities including AI, genetic medicines, biolog...